Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanoma

Technology appraisal guidance
Reference number: TA269
Published: 12 December 2012
Last updated: 01 January 2015

Information for the public

Vemurafenib for unresectable or metastatic melanoma with the BRAF V600 mutation (PDF 182 KB)

Published:

12 December 2012
Gwybodaeth i'r cyhoedd (PDF 180 KB)

Published:

29 May 2013